TY - JOUR
T1 - Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin
AU - Ibrahim, Ahmed H.
AU - Smått, Jan-Henrik
AU - Govardhanam, N Prakirth
AU - Ibrahim, Harry M.
AU - Ismael, Hatem R.
AU - Afouna, Mohsen I.
AU - Samy, Ahmed M.
AU - Rosenholm, Jessica
N1 - 15 January 2020
This journal has an embargo period of 12 months.
Kontaktat [email protected] för byte av version. 10.6.2020. DS
PY - 2020
Y1 - 2020
N2 - Porous carriers have been put forward as a promising alternative for stabilizing the amorphous state of loaded drugs, and thus significantly improving the dissolution rate of poorly soluble compounds. The purpose of this study was to enhance the saturation solubility, dissolution rate and drug loading of the poorly water-soluble drug silymarin via incorporation into mesoporous silica nanospheres within a lyophilized tablet to obtain a unique formulation. 32 full factorial design was applied to study the effect of both independent variables, polyvinyl alcohol (PVA) as stabilizer and binder and sucrose as cryoprotectant and disintegrant; and on the dependent variables that included the mean particle size (Y1), disintegration time (Y2), tablet strength (Y3) and % of drug release after 2 min, R2min,Y4. The drug-loaded mesoporous silica nanospheres and the optimized formula was evaluated by different characterization methods: scanning electron microscopy, transmission electron microscopy, differential scanning calorimetry, X-ray diffractometry and Fourier transform infrared spectroscopy; as well as drug content, saturation solubility and moisture content. The evaluation demonstrated that the loaded mesoporous silica nanospheres and the optimized formula are in amorphous state without any chemical interaction with the silica matrix or the stabilizer. Moreover, the drug was stably maintained in nanosize range with narrow particle size distribution. Furthermore, the optimized lyophilized tablets had highly porous structure, low friability (less than 1%), fast disintegration (less than 30 s), high tablet strength, low moisture content (less than 1%), remarkably increased dissolution rate and noticeable improvement in saturation solubility.
AB - Porous carriers have been put forward as a promising alternative for stabilizing the amorphous state of loaded drugs, and thus significantly improving the dissolution rate of poorly soluble compounds. The purpose of this study was to enhance the saturation solubility, dissolution rate and drug loading of the poorly water-soluble drug silymarin via incorporation into mesoporous silica nanospheres within a lyophilized tablet to obtain a unique formulation. 32 full factorial design was applied to study the effect of both independent variables, polyvinyl alcohol (PVA) as stabilizer and binder and sucrose as cryoprotectant and disintegrant; and on the dependent variables that included the mean particle size (Y1), disintegration time (Y2), tablet strength (Y3) and % of drug release after 2 min, R2min,Y4. The drug-loaded mesoporous silica nanospheres and the optimized formula was evaluated by different characterization methods: scanning electron microscopy, transmission electron microscopy, differential scanning calorimetry, X-ray diffractometry and Fourier transform infrared spectroscopy; as well as drug content, saturation solubility and moisture content. The evaluation demonstrated that the loaded mesoporous silica nanospheres and the optimized formula are in amorphous state without any chemical interaction with the silica matrix or the stabilizer. Moreover, the drug was stably maintained in nanosize range with narrow particle size distribution. Furthermore, the optimized lyophilized tablets had highly porous structure, low friability (less than 1%), fast disintegration (less than 30 s), high tablet strength, low moisture content (less than 1%), remarkably increased dissolution rate and noticeable improvement in saturation solubility.
KW - Poorly soluble drug
KW - Dissolution kinetics
KW - factorial design
KW - Dissolution
KW - Poorly water-soluble drugs
KW - mesoporous materials
KW - Dissolution profile
KW - Poorly soluble drugs
KW - Mesoporous silica
KW - Micro-Mesoporous material
KW - Poorly soluble drug
KW - Dissolution kinetics
KW - factorial design
KW - Dissolution
KW - Poorly water-soluble drugs
KW - mesoporous materials
KW - Dissolution profile
KW - Poorly soluble drugs
KW - Mesoporous silica
KW - Micro-Mesoporous material
KW - Poorly soluble drug
KW - Dissolution kinetics
KW - factorial design
KW - Dissolution
KW - Poorly water-soluble drugs
KW - mesoporous materials
KW - Dissolution profile
KW - Poorly soluble drugs
KW - Mesoporous silica
KW - Micro-Mesoporous material
U2 - 10.1016/j.ejps.2019.105103
DO - 10.1016/j.ejps.2019.105103
M3 - Article
SN - 0928-0987
VL - 142
SP - 1
EP - 11
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
ER -